Journals / Respiratory Case Reports / 2015 / Cilt: 4 - Sayı: 1

A Successfully Treated Severe Case of Extensively Drug-Resistant Tuberculosis During Pregnancy

Gebelik Döneminde Başarı ile Tedavi Edilen Ağır Yaygın İlaç Dirençli Tüberküloz Olgusu

Pages
67–71
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, extensively drug-resistant tuberculosis can be treated successfully during gestation and pregnant women should have the option to continue their pregnancy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Thewidespreademergenceofextensivelydrug-resistant tuberculosis is an increasing global health care problem and affects young adults, including women of childbearing age.
📊
Key Findings & Data:The treatment of exten-sively drug-resistant tuberculosis during pregnancy isstillcontroversialandtherapeuticabortionswere previously recommended for pregnant patients.
💡
Conclusion & Impact:In conclusion, extensively drug-resistant tuberculosis can be treated successfully during gestation and pregnant women should have the option to continue their pregnancy.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Thewidespreademergenceofextensivelydrug-resistant tuberculosis is an increasing global health care problem and affects young adults, including women of childbearing age. The treatment of exten-sively drug-resistant tuberculosis during pregnancy isstillcontroversialandtherapeuticabortionswere previously recommended for pregnant patients. We describe herein a severe case of extensively drug-resistant tuberculosis that was successfully treated during pregnancy. The patient delivered a healthy baby and had no signs of relapse eight months after completing the treatment. In conclusion, extensively drug-resistant tuberculosis can be treated successfully during gestation and pregnant women should have the option to continue their pregnancy.

Özet

Yaygın ilaç dirençli tüberküloz artış gösteren bir glo-bal sağlık problemidir ve doğurganlık çağındaki kadınları da içeren genç erişkinleri etkilemektedir. Gebelik döneminde gelişen yaygın ilaç dirençli tüber-küloz olgularının tedavisi hala tartışmalı olup geçmiş-te gebe hastalara terapötik abortus uygulaması öne-rilmiştir. Bu yazıda gebelik sonlandırılmadan başarı ile tedavi edilen yaygın ilaç dirençli bir tüberküloz olgusu sunulmuştur. Hasta sağlıklı bir bebek doğur-muş olup, tedavinin bitiminden 8 ay sonra relapsı işaret eden herhangi bir bulgusu da yoktur. Sonuç olarak, yaygın ilaç dirençli tüberküloz gebelikle birlik-te başarı ile tedavi edilebilir bir hastalıktır ve bu du-rumdaki kadınların gebelliklerini devam ettirme şansı kendilerine tanınmalıdır.

🔖

Cite This Article

ÇİMEN, P., ARI, G., DERELİ, M. Ş., ÜNLÜ, M. (2022). A Successfully Treated Severe Case of Extensively Drug-Resistant Tuberculosis During Pregnancy. Respiratory Case Reports, Cilt: 4 - Sayı: 1, 67–71. https://ajindex.com/articles/588994

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Shah NS, Wright A, Bai GH, Barrera L, Boulahbal F, Martin--Casabona N, et al. Worldwide emergence of ex-- tensively drug--resistant tuberculosis. Emerg Infect Dis 2007; 13:380--7. CrossRef Jacobson KR, Tierney DB, Jeon CY, Mitnick CD, Murray MB. Treatment outcomes among patients with extensively drug--resistant tuberculosis: systematic review and meta-- analysis. Clin Infect Dis 2010; 51:6--14. CrossRef Joshi JM. Tuberculosis chemotherapy in the 21 st century: Back to the basics. Lung India 2011; 28:193--200. rossRef Centers for Disease Control and Prevention. Emergence of Mycobacterium tuberculosis with extensive resistance to second--line drugs--worldwide, 2000--2004. MMWR Morb Mortal Wkly Rep 2006; 55:301--5. Centers for Disease Control and Prevention. Notice to readers: revised definition of extensively drug--resistant tu-- berculosis. MMWR Morb Mortal Wk|y Rep 2006; 55:1 76. World Health Organization (WHO) Global tuberculosis report 2013. Access date: 23 October 2013. Place of access Türkiye'de Verem Savaşı 2011 Raporu. Access date: November 2012.
  2. Place of access Ferincek G, Tabakoğlu E, Otkun M, Özdemir L, Özdemir B. Mycobacterium tuberculosis Üremesi saptanan akciğer tüberkülozlu hastaların antitüberküloz ilaçlara direnç oranları. Tur Toraks Der 2011; 12:111--3. Farmer P, Bayona J, Becerra M. Multidrug resistant tu-- berculosis and the need for biosocial perspectives. Int Tuberc Lung Dis 2001; 5:885--6. Zaman K, Rahim Z, Yunus M, Arifeen S, Baqui A, Sack D, et 01. Drug resistance of Mycobacterium tuberculosis in selected urban and rural areas in Bangladesh. Scand Infect Dis 2005; 37:21--6. CrossRef Espinal MA, Laserson K, Camacho M, Fusheng Z, Kim SJ, T|a|i RE, et al. Determinants of drug--resistant tuberculosis: analysis of 11 countries. Int Tuberc Lung Dis 2001; 5:887--93. Caminero JA, Sotgiu G, Zumla A, Migliori GB. Best drug treatment for multidrug--resistant and extensively drug-- resistant tuberculosis. Lancet Infect Dis 2010; 10:621--9. CrossRef Nitta AT, Milligan D. Management of four pregnant women with multi--drug resistant tuberculosis. Clin Infect Dis 1999; 28:1298--304. Drobac PC, del Castillo H, Sweetland A, Anca G, Joseph JK, Furin J, et al. Treatment of multidrug resistant tuber-- culosis during pregnancy: long--term follow--up of chil-- dren with intrauterine exposure to second--line agents. Clin Infect Dis 2005; 40:1689--92. CrossRef Lessnau KD, Qarah S. Multi--drug resistant tuberculosis in pregnancy: case report and review of th